Economy & Markets
Price caps sound great — until you have cancer and a two-year waitlist
Importing European drug price controls to the U.S. threatens cancer patients with deadly care delays and stifles medical research.
Read more at EXAMINER ›
Read the full story at
EXAMINER
The Gadsden Report aggregates and summarises headlines. The reporting above belongs to EXAMINER, and the link opens their page. This page exists so readers can find, share, and discuss the story here.